Condition: Acquired Blepharophimosis · Sponsor: Santen SAS
A Randomised, Double-Masked, Placebo-Controlled Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops) used twice daily (BID) in the Treatment of Acquired Blepharoptosis
This description comes directly from the study's public registry record.
Santen SAS Clinical Operations · +31 683 667 357 · edith.vandijkman@santen.com
Always discuss trial participation with your own doctor first.
| Oftex.s.r.o, oční klinika | Pardubice, Czechia | Recruiting |
| Fakultni nemocnice Plzeň, Oční oddělení | Pilsen, Czechia | Recruiting |
| Fakultni Thomayerova nemocnice | Prague, Czechia | Recruiting |
| Clinique Ophtalmologique Thiers | Bordeaux, France | Recruiting |
| CHU Rennes - PONTCHAILLOU Service ophtalmologie | Guillon, France | Recruiting |
| Hôpital Fondation Adolphe de Rothschild | Paris, France | Recruiting |
| CHU de Saint Etienne - Hôpital NORD Service d'Ophtalmologie | Saint-Etienne, France | Recruiting |
| Unversitaetsmedizin Goettingen | Goettigen, Germany | Recruiting |
| Universitätsmedizin Göttingen; Georg-August-Universität | Göttingen, Germany | Recruiting |
| Budapest Retina Associates | Budapest, Hungary | Recruiting |
| Budapesti Jahn Ferenc Dél-Pesti Kórház és Rendelőintézet | Budapest, Hungary | Recruiting |
| Észak-Pesti Centrumkórház - Honvédkórház | Budapest, Hungary | Recruiting |
+ 24 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06514612